Avidity Biosciences
RNA
#1880
Rank
A$16.24 B
Marketcap
A$107.79
Share price
-0.03%
Change (1 day)
133.52%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: A$16.24 Billion

As of January 2026 Avidity Biosciences has a market cap of A$16.24 Billion. This makes Avidity Biosciences the world's 1880th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$16.24 B0.09%
2025A$16.22 B180.94%
2024A$5.77 B449.14%
2023A$1.05 B-51.47%
2022A$2.16 B40.95%
2021A$1.53 B23.46%
2020A$1.24 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Avidity Biosciences was reported to be:

A$16.24 Billion
by Nasdaq info icon info icon
A$16.24 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
A$9.28 B-42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.22 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$3.30 B-79.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$4.25 B-73.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.18 B-98.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$16.28 B 0.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$214.05 B 1,217.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$151.72 B 834.20%๐Ÿ‡ฌ๐Ÿ‡ง UK